This comprehensive guide provides researchers, scientists, and drug development professionals with current, actionable protocols for creating precise disease models using CRISPR-Cas9.
This article provides a detailed, technical overview of the CRISPR-Cas9 mechanism as applied to sickle cell disease (SCD) gene editing.
This detailed guide provides a complete, step-by-step protocol for performing CRISPR-Cas9 gene editing, tailored for researchers, scientists, and drug development professionals.
This comprehensive guide for researchers and drug developers details the current landscape of CRISPR-Cas9 delivery technologies.
This article provides a detailed, step-by-step protocol for utilizing the CRISPR-Cas12a (Cpf1) system to target thymine (T)-rich genomic regions through its unique TTTN (and TTTV) PAM specificity.
This article provides a detailed, up-to-date exploration of the classification and functional diversity of CRISPR-Cas systems, spanning Types I through VI.
This article provides a detailed technical comparison of CRISPR-Cas9 gene editing and base editing platforms for researchers and drug development professionals.
This article provides a comparative analysis of CRISPR and RNAi screening technologies, focusing on their relative sensitivity in identifying essential genes and novel therapeutic targets.
This article provides a comprehensive, current overview of CRISPR-Cas system toxicity for researchers and drug development professionals.
This article provides a comprehensive analysis of two pioneering high-fidelity CRISPR-Cas9 variants: SpCas9-HF1 and eSpCas9.